Glutaminase activity in GLS1 Het mouse brain compared to putative pharmacological inhibition by ebselen using ex vivo MRS.


Journal

Neurochemistry international
ISSN: 1872-9754
Titre abrégé: Neurochem Int
Pays: England
ID NLM: 8006959

Informations de publication

Date de publication:
10 2019
Historique:
received: 17 05 2019
revised: 28 06 2019
accepted: 18 07 2019
pubmed: 22 7 2019
medline: 12 5 2020
entrez: 22 7 2019
Statut: ppublish

Résumé

Glutaminase mediates the recycling of neurotransmitter glutamate, supporting most excitatory neurotransmission in the mammalian central nervous system. A constitutive heterozygous reduction in GLS1 engenders in mice a model of schizophrenia resilience and associated increases in Gln, reductions in Glu and activity-dependent attenuation of excitatory synaptic transmission. Hippocampal brain slices from GLS1 heterozygous mice metabolize less Gln to Glu. Whether glutaminase activity is diminished in the intact brain in GLS1 heterozygous mice has not been assessed, nor the regional impact. Moreover, it is not known whether pharmacological inhibition would mimic the genetic reduction. We addressed this using magnetic resonance spectroscopy to assess amino acid content and

Identifiants

pubmed: 31326460
pii: S0197-0186(19)30263-3
doi: 10.1016/j.neuint.2019.104508
pmc: PMC6941670
mid: NIHMS1064162
pii:
doi:

Substances chimiques

Amino Acids 0
Azoles 0
Isoindoles 0
Nerve Tissue Proteins 0
Organoselenium Compounds 0
ebselen 40X2P7DPGH
gamma-Aminobutyric Acid 56-12-2
GLS1 protein, mouse EC 3.5.1.2
Glutaminase EC 3.5.1.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104508

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH087758
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH109159
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH117128
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

JAMA Neurol. 2019 Mar 1;76(3):342-350
pubmed: 30575854
Mol Imaging. 2018 Jan-Dec;17:1536012118788636
pubmed: 30213221
Neurochem Int. 2011 Sep;59(4):473-81
pubmed: 21397652
J Neurochem. 1993 Feb;60(2):395-407
pubmed: 8419527
J Neurosci. 2006 Apr 26;26(17):4660-71
pubmed: 16641247
Eur Neuropsychopharmacol. 2014 Dec;24(12):1916-24
pubmed: 25453483
Free Radic Biol Med. 1993 Mar;14(3):313-23
pubmed: 8458589
J Neurosci Res. 2015 Jul;93(7):1031-44
pubmed: 25648608
Neuroscientist. 2002 Dec;8(6):562-73
pubmed: 12467378
Neurochem Res. 2002 Apr;27(4):283-8
pubmed: 11958529
Hippocampus. 2012 May;22(5):1027-39
pubmed: 22431402
AJNR Am J Neuroradiol. 1995 Oct;16(9):1763-70
pubmed: 8693972
Bosn J Basic Med Sci. 2015 Aug 26;15(4):36-43
pubmed: 26614850
Neuropsychopharmacology. 2009 Sep;34(10):2305-22
pubmed: 19516252
J Cereb Blood Flow Metab. 2012 May;32(5):816-24
pubmed: 22373647
Schizophr Bull. 2019 Jan 1;45(1):127-137
pubmed: 29471549
Psychiatry Res Neuroimaging. 2016 Feb 28;248:1-11
pubmed: 26803479
J Neurochem. 2009 Apr;109(2):494-501
pubmed: 19200336
J Neurochem. 1979 Jul;33(1):339-42
pubmed: 37288
ACS Chem Biol. 2017 Dec 15;12(12):3003-3011
pubmed: 29072450
Annu Rev Nutr. 1995;15:133-59
pubmed: 8527215
J Immunol. 2002 Jul 15;169(2):974-82
pubmed: 12097404
Front Syst Neurosci. 2016 Jan 08;9:165
pubmed: 26778975
Assay Drug Dev Technol. 2018 Feb/Mar;16(2):115-122
pubmed: 29470101
Nat Commun. 2013;4:1332
pubmed: 23299882
Expert Rev Neurother. 2012 Jul;12(7):785-99
pubmed: 22853787
Psychopharmacology (Berl). 2016 Mar;233(6):1097-104
pubmed: 26758281
Neuron. 2014 Sep 3;83(5):1073-1084
pubmed: 25132466
J Cereb Blood Flow Metab. 2015 Jul;35(7):1169-74
pubmed: 25806702
Schizophr Bull. 2009 Nov;35(6):1037-44
pubmed: 19828591
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2699-704
pubmed: 9122259
J Nucl Med. 2013 Nov;54(11):1954-61
pubmed: 24050937
J Neurosci. 2004 Dec 15;24(50):11273-9
pubmed: 15601933
FEBS Open Bio. 2014 Jan 06;4:77-89
pubmed: 24490132
Biochem Biophys Res Commun. 2013 Aug 23;438(2):243-8
pubmed: 23850693
Anal Chem. 2017 Feb 7;89(3):1689-1696
pubmed: 28208301
Synapse. 2013 Aug;67(8):489-501
pubmed: 23424090
J Cereb Blood Flow Metab. 2007 Dec;27(12):1895-907
pubmed: 17440492
Neurochem Int. 2004 Jul-Aug;45(2-3):285-96
pubmed: 15145544
J Cereb Blood Flow Metab. 2010 Jun;30(6):1200-13
pubmed: 20125180

Auteurs

Lauren Kosten (L)

Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.

Golam M I Chowdhury (GMI)

Department of Psychiatry, Magnetic Resonance Research Center, Yale University School of Medicine, USA.

Susana Mingote (S)

Department of Psychiatry, Columbia University, USA; Department of Molecular Therapeutics, NYS Psychiatric Institute, USA; Neuroscience, Advanced Science Research Center at the Graduate Center of the City University of New York, USA.

Steven Staelens (S)

Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.

Douglas L Rothman (DL)

Department of Radiology & Biomedical Imaging, Magnetic Resonance Research Center, Yale University School of Medicine, USA.

Kevin L Behar (KL)

Department of Psychiatry, Magnetic Resonance Research Center, Yale University School of Medicine, USA. Electronic address: Kevin.behar@yale.edu.

Stephen Rayport (S)

Department of Psychiatry, Columbia University, USA; Department of Molecular Therapeutics, NYS Psychiatric Institute, USA. Electronic address: stephen.rayport@nyspi.columbia.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH